Clinical Trial Update: FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis [Phase 3]

View source ↗

Summary

Phase 3 trial update for FS-1 in treating multi-drug resistant tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multi-drug Resistant Tuberculosis
• Tuberculosis

Drugs mentioned

• FS-1

Snippet

Sponsor: Scientific Center for Anti-infectious Drugs, Kazakhstan | Conditions: Tuberculosis, MDR | Phase 3 | Status: COMPLETED